保存されたエジェクション分数による心不全の臨床前モデル:デバイスベースの治療のための知識の進歩
Nina Langer1,2, Andreas Escher3, Caglar Ozturk4
1Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia. nina.langer@monash.edu.
Annals of biomedical engineering
|August 25, 2025
まとめ
発射分子が保存された心不全 (HFpEF) は,世界的な健康問題です. このレビューでは,HFpEFの診断を改善し,効果的なデバイス治療を開発するための臨床前モデルを検証します.
科学分野:
- 心臓病科
- 生物医学工学
背景:
- HFpEF (保存されたエジェクション分数を持つ心不全) は,全世界の心不全症例の半分に影響します.
- HFpEFの診断と治療を複雑にする.
- HFpEFの現在の治療は,患者の異質性により,有効性が限られている.
研究 の 目的:
- HFpEFの現在の臨床前モデルをレビューする.
- これらのモデルの有用性を評価し,HFpEFの理解とデバイス治療の開発を進める.
主な方法:
- in-silico,in-vitro,ex-vivo,およびin-vivoの臨床前モデルの概要
- 各モデルのHFpEF特性を再現する能力の評価
- モデルの強度,限界,および臨床的関連性についての議論.
主要な成果:
- 臨床前モデルは,HFpEFの病理生理学を理解するために不可欠です.
- 様々なモデルがHFpEFを研究する際の 明確な利点を提示しています
- 単一のモデルはHFpEFの複雑さを完全に捉えることができず,組み合わせたアプローチが必要になります.
結論:
- HFpEFに対する効果的なデバイスベースの治療法の開発には,改善された臨床前モデルが不可欠です.
- 新興モデルの進歩に関するさらなる研究が必要である.
- これらのモデルは,臨床的に重要なHFpEFソリューションの作成を導くでしょう.
関連する概念動画
01:29Heart Failure II: Pathophysiology
38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
01:30Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22